C07D 407/14
Containing three or more hetero rings
Official title: containing three or more hetero rings
C07D407/14 (Containing three or more hetero rings) appears on 750 US grants and 961 published applications in this corpus.
Search patents in C07D- Granted patents
- 750
- Published applications
- 961
- Assignees
- 469
- Inventors
- 3,364
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 6 | 0 |
| 1984 | 2 | 0 |
| 1985 | 5 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 8 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 9 | 0 |
| 2001 | 7 | 1 |
| 2002 | 6 | 5 |
| 2003 | 14 | 28 |
| 2004 | 7 | 17 |
| 2005 | 7 | 16 |
| 2006 | 10 | 15 |
| 2007 | 5 | 23 |
| 2008 | 13 | 23 |
| 2009 | 19 | 36 |
| 2010 | 18 | 32 |
| 2011 | 20 | 35 |
| 2012 | 25 | 47 |
| 2013 | 36 | 45 |
| 2014 | 55 | 47 |
| 2015 | 43 | 58 |
| 2016 | 39 | 47 |
| 2017 | 31 | 42 |
| 2018 | 31 | 40 |
| 2019 | 43 | 67 |
| 2020 | 56 | 81 |
| 2021 | 50 | 48 |
| 2022 | 30 | 46 |
| 2023 | 36 | 53 |
| 2024 | 27 | 52 |
| 2025 | 33 | 27 |
| 2026 | 13 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Quinoxaline derivatives and uses thereof22 Sep 2026US 12,741,976 B2Black Diamond Therapeutics, Inc.
- Substituted triazine compound28 Jul 2026US 12,692,241 B2Nico Therapeutics, Inc.
- Monomers for non-isocyanate polyurethanes23 Jun 2026US 12,662,574 B2Alliance for Energy Innovation, LLC
- Epoxy resin16 Jun 2026US 12,655,248 B2Commonwealth Scientific and Industrial Research Organisation
- Heteroaryl-substituted imidazole derivatives7 Apr 2026US 12,595,255 B2Hoffmann-La Roche Inc.
- Substituted triazine compound1 Oct 2026US 2026/0297040 A1
- Compounds for the degradation of mutant braf1 Oct 2026US 2026/0297060 A1C4 Therapeutics, Inc.
- Biobased polyesters and methods of making and using same24 Sep 2026US 2026/0286044 A1Solugen, Inc.
- Nlrp3 modulators17 Sep 2026US 2026/0272920 A1Zomagen Biosciences Ltd
- 1h-pyrrole-2-amide derivative, pharmaceutical composition and method for treating and/or preventing ythdc1-related diseases10 Sep 2026US 2026/0265222 A1Chongqing Pharscin Innobio Co., Ltd.
Most cited
By later US patents
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-pyrimidinediamine compounds and their uses176US 7,557,210 B2Rigel Pharmaceuticals, Inc. · 2009
- 2,4-pyrimidinediamine compounds and their uses119US 7,329,671 B2Rigel Pharmaceuticals, Inc. · 2008
- 2,4-pyrimidinediamine compounds and their uses114US 7,332,484 B2Rigel Pharmaceuticals, Inc. · 2008
- Pyrazole compounds useful as protein kinase inhibitors109US 6,664,247 B2Vertex Pharmaceuticals Incorporated · 2003